Board
Since its incorporation in September 2013 – the Board governs IDHDP. The Board is comprised of five highly qualified members who are listed below.
Dr Judith Yates |
|
 |
Dr Judith Yates has been a family doctor near the centre of Birmingham UK, for thirty years, specialising in working with people who use drugs and alcohol and over the last two years she has worked in a residential detox unit. Judith has played a key role in advocating for the provision of take home Naloxone. She has been part of a Naloxone Steering Group, which has extended the provision of take-home Naloxone across Birmingham. Judith is a founding member of the Independent Consortium on Drug Consumption Rooms and supports harm reduction measures which reduce morbidity associated with the use of drugs and alcohol. |
Sidney H. Schnoll, M.D., Ph.D. |
|
| Sidney H. Schnoll, M.D., Ph.D., is an internationally recognized expert in addiction and pain management. Sid also developed the RADARS® System to study the use and diversion of prescription opioids, which was cited by the FDA as a model risk management program. Sid has received numerous awards including listings in The Best Doctors in America and is a Fellow of CPDD and the American Society of Addiction Medicine. With over thirty years in academic medicine, Sid has published over 150 research papers, book chapters and educational materials. His areas of research include both addiction and pain management with special emphasis on perinatal addiction and prescription drug abuse. |
 |
 |
|
||||
Professor Graham Foster |
|
|
|
Professor Foster is the Professor of Hepatology at Queen Marys University of London and a consultant hepatologist at Barts Health in East London. He has a long standing interest in chronic viral hepatitis and leads a number of national and international clinical trials evaluating new approaches to therapy. He runs clinical and laboratory research programs studying the pathophysiology and virology of hepatitis C. Graham is involved in pioneering schemes to ensure that those who actively use illicit drugs have equal access to all necessary health care and he leads a team providing community access to drug users afflicted by viral hepatitis. |
|
|
|
Professor Carl Hart
|
Carl Hart is an associate professor of psychology at Columbia University, a member of the National Advisory Council on Drug Abuse, and the director of the Methamphetamine Research Laboratories at the New York State Psychiatric Institute. His research focuses on the neuropsychopharmacological effects of psychoactive drugs in humans. In 2013, he published his best-selling book, “High Price: A Neuroscientist’s Journey of Self-Discovery That Challenges Everything You Know About Drugs and Society.” High Price was the 2014 winner of the PEN/E.O. Wilson Literary Science Writing Award. |
 |
